{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T09:10:33Z","timestamp":1739869833907,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shandong Provincial Medical and Health Science and Technology Development Plan","award":["202303041419","202314011476"],"award-info":[{"award-number":["202303041419","202314011476"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-90436-y","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T08:36:45Z","timestamp":1739867805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Retrospective analysis of clinical data from 171 low-income patients with hemophilia in Shandong Province"],"prefix":"10.1038","volume":"15","author":[{"given":"Jie","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunhai","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuicui","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiantian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hehe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"90436_CR1","doi-asserted-by":"publisher","unstructured":"Srivastava, A. et al. Guidelines for the management of hemophilia. Haemophilia 19 (1), e1-47. (2013). https:\/\/doi.org\/10.1111\/j.1365-2516. 2012. 02909.x.","DOI":"10.1111\/j.1365-2516"},{"issue":"10040","key":"90436_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0140-6736(15)01123-X","volume":"388","author":"F Peyvandi","year":"2016","unstructured":"Peyvandi, F., Garagiola, I. & Young, G. The past and future of haemophilia: diagnosis, treatments, and its complications. Lancet 388 (10040), 187\u2013197. https:\/\/doi.org\/10.1016\/S0140-6736(15)01123-X (2016).","journal-title":"Lancet"},{"issue":"23","key":"90436_CR3","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJM200106073442307","volume":"344","author":"PM Mannucci","year":"2001","unstructured":"Mannucci, P. M. & Tuddenham, E. G. The hemophilias\u2013from royal genes to gene therapy. N Engl. J. Med. 344 (23), 1773\u20131779. https:\/\/doi.org\/10.1056\/NEJM200106073442307 (2001).","journal-title":"N Engl. J. Med."},{"issue":"4","key":"90436_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1046\/j.1365-2516.1998.440341.x","volume":"4","author":"LM Aledort","year":"1998","unstructured":"Aledort, L. M. Unsolved problems in haemophilia. Haemophilia 4 (4), 341\u2013345. https:\/\/doi.org\/10.1046\/j.1365-2516.1998.440341.x (1998).","journal-title":"Haemophilia"},{"key":"90436_CR5","doi-asserted-by":"publisher","unstructured":"Lee, C. A. Towards achieving global haemophilia care\u2013World Federation of Hemophilia programmes. Haemophilia (4), 463\u2013473. https:\/\/doi.org\/10.1046\/j.1365-2516.1998.440463.x (1998).","DOI":"10.1046\/j.1365-2516.1998.440463.x"},{"issue":"1","key":"90436_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1365-2516.2009.02131.x","volume":"16","author":"JS Stonebraker","year":"2010","unstructured":"Stonebraker, J. S. et al. A study of reported factor VIII use around the world. Haemophilia 16 (1), 33\u201346. https:\/\/doi.org\/10.1111\/j.1365-2516.2009.02131.x (2010).","journal-title":"Haemophilia"},{"issue":"12","key":"90436_CR7","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/17474086.2023.2293092","volume":"16","author":"T Ampaiwan Chuansumrit","year":"2023","unstructured":"Ampaiwan Chuansumrit, T. et al. National strategic advocacy to manage patients with inherited bleeding disorders in low and lower-middle income countries. Expert Rev. Hematol. 16 (12), 1063\u20131076. https:\/\/doi.org\/10.1080\/17474086.2023.2293092 (2023).","journal-title":"Expert Rev. Hematol."},{"issue":"S6","key":"90436_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hae.14046","volume":"26","author":"A Srivastava","year":"2020","unstructured":"Srivastava, A. et al. WFH guidelines for the management of Hemophilia, 3rd edition. Haemophilia 26 (S6), 1\u2013158. https:\/\/doi.org\/10.1111\/hae.14046 (2020).","journal-title":"Haemophilia"},{"issue":"4","key":"90436_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1365-2516.2012.02765.x","volume":"18","author":"K Lindvall","year":"2012","unstructured":"Lindvall, K. et al. Quality of life in adult patients with haemophilia - a single centre experience from Sweden. Haemophilia 18 (4), 527\u2013531. https:\/\/doi.org\/10.1111\/j.1365-2516.2012.02765.x (2012).","journal-title":"Haemophilia"},{"issue":"Suppl 5","key":"90436_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1365-2516.2012.02890.x","volume":"18","author":"MC Ozelo","year":"2012","unstructured":"Ozelo, M. C. et al. Meeting the challenges of haemophilia care and patient support in China and Brazil. Haemophilia 18 (Suppl 5), 33\u201338. https:\/\/doi.org\/10.1111\/j.1365-2516.2012.02890.x (2012).","journal-title":"Haemophilia"},{"issue":"5","key":"90436_CR11","doi-asserted-by":"publisher","first-page":"e12764","DOI":"10.1002\/rth2.12764","volume":"6","author":"C Qu","year":"2022","unstructured":"Qu, C. et al. Analysis of hospitalization of people withhemophilia-12 years of experience in a single center. Res. Pract. Thromb. Haemostasis. 6 (5), e12764. https:\/\/doi.org\/10.1002\/rth2.12764 (2022).","journal-title":"Res. Pract. Thromb. Haemostasis"},{"issue":"1","key":"90436_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4103\/09736247.164269","volume":"10","author":"V Payal","year":"2016","unstructured":"Payal, V. et al. Clinical profile of hemophilia patients in Jodhpur Region. Asian J. Transfus. Sci. 10 (1), 101\u2013104. https:\/\/doi.org\/10.4103\/09736247.164269 (2016).","journal-title":"Asian J. Transfus. Sci."},{"issue":"1","key":"90436_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-021-00278-x","volume":"7","author":"E Berntorp","year":"2021","unstructured":"Berntorp, E. et al. Nat. Rev. Dis. Primers 7(1):45. https:\/\/doi.org\/10.1038\/s41572-021-00278-x. (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"Suppl 6","key":"90436_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1365-2516.2008.01882.x","volume":"14","author":"G Roosendaal","year":"2008","unstructured":"Roosendaal, G. et al. Haemophilic arthropathy: the importance of the earliest haemarthroses and consequences for treatment. Haemophilia 14 (Suppl 6), 4\u201310. https:\/\/doi.org\/10.1111\/j.1365-2516.2008.01882.x (2008).","journal-title":"Haemophilia"},{"issue":"4","key":"90436_CR15","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/hae.14312","volume":"27","author":"C Daffunchio","year":"2021","unstructured":"Daffunchio, C. et al. Clinical and ultrasound evaluation of patients with haemophilia on prophylaxis. Haemophilia 27 (4), 641\u2013647. https:\/\/doi.org\/10.1111\/hae.14312 (2021).","journal-title":"Haemophilia"},{"key":"90436_CR16","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1046\/j.1365-2141.1999.01631.x","volume":"106","author":"RC Ljung","year":"1999","unstructured":"Ljung, R. C. & Sjorin, E. Origin of mutation in sporadic cases of haemophilia A. Br. J. Haematol. 106, 870\u2013874 (1999).","journal-title":"Br. J. Haematol."},{"issue":"1","key":"90436_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s13023-022-02413-7.18","volume":"17","author":"MN Islam","year":"2022","unstructured":"Islam, M. N. et al. Clinical profile and demographic characteristics of moderate and severe hemophilia patients in a tertiary care hospital of Bangladesh. Orphanet J. Rare Dis. 17 (1), 254. https:\/\/doi.org\/10.1186\/s13023-022-02413-7.18 (2022).","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"90436_CR18","doi-asserted-by":"publisher","first-page":"308","DOI":"10.5114\/aoms.2020.92892","volume":"16","author":"HM Peng","year":"2020","unstructured":"Peng, H. M. et al. Transfusion-transmitted infections in hemophilia patients who underwent surgical treatment: a study from a single center in north China. Arch. Med. Sci. 16 (2), 308\u2013312. https:\/\/doi.org\/10.5114\/aoms.2020.92892 (2020).","journal-title":"Arch. Med. Sci."},{"issue":"24","key":"90436_CR19","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1182\/blood-2015-10-675140","volume":"127","author":"MA Mazepa","year":"2016","unstructured":"Mazepa, M. A. et al. Men with severe hemophilia in the United States: birth cohort analysis of a large national database. Blood 127 (24), 3073\u20133081. https:\/\/doi.org\/10.1182\/blood-2015-10-675140 (2016).","journal-title":"Blood"},{"issue":"6","key":"90436_CR20","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/jac\/dkn119","volume":"61","author":"M Franchini","year":"2008","unstructured":"Franchini, M. et al. Treatment of chronic hepatitis C in haemophilic patients with interferon and Ribavirin: a meta-analysis. J. Antimicrob. Chemother. 61 (6), 1191\u20131200. https:\/\/doi.org\/10.1093\/jac\/dkn119 (2008).","journal-title":"J. Antimicrob. Chemother."},{"issue":"7","key":"90436_CR21","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1182\/blood-2008-07-077370","volume":"112","author":"HJ Alter","year":"2008","unstructured":"Alter, H. J. & Klein, H. G. The hazards of blood transfusion in historical perspective. Blood 112 (7), 2617\u20132626. https:\/\/doi.org\/10.1182\/blood-2008-07-077370 (2008).","journal-title":"Blood"},{"issue":"7","key":"90436_CR22","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1111\/jth.13711","volume":"15","author":"AS van Velzen","year":"2017","unstructured":"van Velzen, A. S. et al. Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia a patients: results of the INSIGHT case-control study. J. Thromb. Haemostasis: JTH. 15 (7), 1422\u20131429. https:\/\/doi.org\/10.1111\/jth.13711 (2017).","journal-title":"J. Thromb. Haemostasis: JTH"},{"issue":"1","key":"90436_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13023-018-0800-z","volume":"13","author":"PLF Giangrande","year":"2018","unstructured":"Giangrande, P. L. F. et al. European principles of inhibitor management in patients with haemophilia. Orphanet J. Rare Dis. 13 (1), 66. https:\/\/doi.org\/10.1186\/s13023-018-0800-z (2018).","journal-title":"Orphanet J. Rare Dis."},{"issue":"15","key":"90436_CR24","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1182\/blood-2017-06-791756","volume":"130","author":"FR Rosendaal","year":"2017","unstructured":"Rosendaal, F. R. et al. Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis. Blood 130 (15), 1757\u20131759. https:\/\/doi.org\/10.1182\/blood-2017-06-791756 (2017).","journal-title":"Blood"},{"issue":"3","key":"90436_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1182\/blood.2019000658","volume":"134","author":"HM van den Berg","year":"2019","unstructured":"van den Berg, H. M. et al. Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A. Blood 134 (3), 317\u2013320. https:\/\/doi.org\/10.1182\/blood.2019000658 (2019).","journal-title":"Blood"},{"key":"90436_CR26","doi-asserted-by":"publisher","unstructured":"Franchini, M. et al. Systematic review of the role of FVIII concentrates in inhibitor development in previously untreated patients with severe hemophilia a: a 2013 update. Semin Thromb Hemost 2013, 39 (7), 752\u2009\u2013\u200966. (2013). https:\/\/doi.org\/10.1055\/s-0033-1356715","DOI":"10.1055\/s-0033-1356715"},{"issue":"5","key":"90436_CR27","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1160\/TH14-07-0621","volume":"113","author":"M Marcucci","year":"2015","unstructured":"Marcucci, M. et al. Type and intensity of FVIII exposure on inhibitor development in PUPs with haemophilia A. A patient-level meta-analysis. Thromb. Haemost. 113 (5), 958\u2013967. https:\/\/doi.org\/10.1160\/TH14-07-0621 (2015).","journal-title":"Thromb. Haemost"},{"issue":"4","key":"90436_CR28","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1046\/j.1365-2516.2003.00780.x","volume":"9","author":"J Wight","year":"2003","unstructured":"Wight, J. & Paisley, S. The epidemiology of inhibitors in haemophilia A: a systematic review. Haemophilia 9 (4), 418\u2013435. https:\/\/doi.org\/10.1046\/j.1365-2516.2003.00780.x (2003).","journal-title":"Haemophilia"},{"issue":"21","key":"90436_CR29","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1056\/NEJMoa1516437","volume":"374","author":"F Peyvandi","year":"2016","unstructured":"Peyvandi, F., Mannucci, P. M., Garagiola, I. & ea tl. Randomized Trial of Factor VIII and neutralizing antibodies in Hemophilia A. N Engl. J. Med. 374 (21), 2054\u20132064. https:\/\/doi.org\/10.1056\/NEJMoa1516437 (2016).","journal-title":"N Engl. J. Med."},{"key":"90436_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5114\/aoms.2010.13512","volume":"6","author":"P Eshghi","year":"2010","unstructured":"Eshghi, P. et al. Haemophilia in the developing countries: the Iranian experience. Arch. Med. Sci. 6, 83\u201389. https:\/\/doi.org\/10.5114\/aoms.2010.13512 (2010).","journal-title":"Arch. Med. Sci."},{"key":"90436_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/hae.13862","volume":"26","author":"MW Skinner","year":"2020","unstructured":"Skinner, M. W. et al. Achieving the unimaginable: health equity in haemophilia. Haemophilia 26, 17\u201324. https:\/\/doi.org\/10.1111\/hae.13862 (2020).","journal-title":"Haemophilia"},{"key":"90436_CR32","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1046\/j.1351-8216.2003.00831.x","volume":"9","author":"P Jones","year":"2003","unstructured":"Jones, P. & Robillard, L. The World Federation of Hemophilia: 40 years of improving haemophilia care worldwide. Haemophilia 9, 663\u2013669. https:\/\/doi.org\/10.1046\/j.1351-8216.2003.00831.x (2003).","journal-title":"Haemophilia"},{"key":"90436_CR33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1055\/s-2005-922228","volume":"31","author":"B O\u2019Mahony","year":"2005","unstructured":"O\u2019Mahony, B. & Black, C. Expanding hemophilia care in developing countries. Semin Thromb. Hemost. 31, 561\u2013568. https:\/\/doi.org\/10.1055\/s-2005-922228 (2005).","journal-title":"Semin Thromb. Hemost."},{"issue":"3","key":"90436_CR34","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/jth.12828","volume":"13","author":"K Kavakli","year":"2015","unstructured":"Kavakli, K. et al. Prophylaxis vs. on-demand treatment with BAY 81-8973, a full-length plasma protein-free recombinant factor VIII product: results from a randomized trial (LEOPOLD II). J. Thromb. Haemostasis: JTH. 13 (3), 360\u2013369. https:\/\/doi.org\/10.1111\/jth.12828 (2015).","journal-title":"J. Thromb. Haemostasis: JTH"},{"issue":"2","key":"90436_CR35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/hae.14256","volume":"27","author":"Y Wu","year":"2021","unstructured":"Wu, Y. et al. Long-term joint outcomes of regular low-dose prophylaxis in Chinese children with severe haemophilia A. Haemophilia 27 (2), 237\u2013244. https:\/\/doi.org\/10.1111\/hae.14256 (2021).","journal-title":"Haemophilia"},{"issue":"4","key":"90436_CR36","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/hae.14012","volume":"26","author":"JS Stonebraker","year":"2020","unstructured":"Stonebraker, J. S. et al. The World Federation of Hemophilia Annual Global Survey 1999\u20132018. Haemophilia 26 (4), 591\u2013600. https:\/\/doi.org\/10.1111\/hae.14012 (2020).","journal-title":"Haemophilia"},{"key":"90436_CR37","doi-asserted-by":"publisher","unstructured":"Gringeri, A. et al. A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study). J. Thromb. Haemostasis: JTH. 9 (4). https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04214.x (2011). 700\u2009\u2013\u200910.","DOI":"10.1111\/j.1538-7836.2011.04214.x"},{"key":"90436_CR38","doi-asserted-by":"publisher","unstructured":"Wilkins, R. A. et al. Twelve-month prevalence of haemarthrosis and joint disease using the Haemophilia Joint Health score: evaluation of the UK National Haemophilia database and haemtrack patient reported data: an observational study. BMJ Open. 12 (1). https:\/\/doi.org\/10.1136\/bmjopen-2021-052358 (2022).","DOI":"10.1136\/bmjopen-2021-052358"},{"issue":"2","key":"90436_CR39","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/hae.14720","volume":"29","author":"RA Wilkins","year":"2022","unstructured":"Wilkins, R. A. et al. The impact of ankle haemarthropathy in patients with moderate haemophilia. Haemophilia 29 (2), 600\u2013607. https:\/\/doi.org\/10.1111\/hae.14720 (2022).","journal-title":"Haemophilia"},{"key":"90436_CR40","doi-asserted-by":"publisher","unstructured":"Li, Y. et al. Comparison of joint status using ultrasound assessments and Haemophilia Joint Health score 2.1 in children with haemophilia. Front. Med. 10 https:\/\/doi.org\/10.3389\/fmed.2023.1193830 (2023).","DOI":"10.3389\/fmed.2023.1193830"},{"issue":"1","key":"90436_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/hae.14171","volume":"27","author":"S O\u2019Hara","year":"2021","unstructured":"O\u2019Hara, S. et al. Disease burden and remaining unmet need in patients with haemophilia a treated with primary prophylaxis. Haemophilia 27 (1), 113\u2013119. https:\/\/doi.org\/10.1111\/hae.14171 (2021).","journal-title":"Haemophilia"},{"issue":"2","key":"90436_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/hae.14278","volume":"27","author":"J O\u2019Hara","year":"2021","unstructured":"O\u2019Hara, J. et al. Evidence of a disability paradox in patient-reported outcomes in haemophilia. Haemophilia 27 (2), 245\u2013252. https:\/\/doi.org\/10.1111\/hae.14278 (2021).","journal-title":"Haemophilia"},{"issue":"8","key":"90436_CR43","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/s0277-9536(98)00411-0","volume":"48","author":"GL Albrecht","year":"1999","unstructured":"Albrecht, G. L. & Devlieger, P. J. The disability paradox: high quality of life against all odds. Soc. Sci. Med. 48 (8), 977\u2013988. https:\/\/doi.org\/10.1016\/s0277-9536(98)00411-0 (1999).","journal-title":"Soc. Sci. Med."},{"issue":"1","key":"90436_CR44","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13023-017-0660-y","volume":"12","author":"J O\u2019Hara","year":"2017","unstructured":"O\u2019Hara, J. et al. The cost of severe haemophilia in Europe: the CHESS study. Orphanet J. Rare Dis. 12 (1), 106. https:\/\/doi.org\/10.1186\/s13023-017-0660-y (2017).","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"90436_CR45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13023-021-01919-w","volume":"16","author":"J Sun","year":"2021","unstructured":"Sun, J. et al. Factor VIII replacement prophylaxis in patients with hemophilia A transitioning to adults: a systematic literature review. Orphanet J. Rare Dis. 16 (1), 287. https:\/\/doi.org\/10.1186\/s13023-021-01919-w (2021).","journal-title":"Orphanet J. Rare Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90436-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90436-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90436-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T08:36:49Z","timestamp":1739867809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90436-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["90436"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-90436-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"26 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5867"}}